
Including patient stories in health education materials and patient decision aids might seem like an obvious choice, for many reasons:
- They are vivid, engaging readers or viewers with the material.
- They have inherent credibility when told by people who have “been there.”
- They can provide useful information about health decisions in less boring ways than traditional formats.
- They can show diversity, either in terms of patient demographics (i.e., “somebody who looks like me”) and/or values (“somebody who thinks like I do”).
Seems like a win-win, right?
Well, sometimes.
On the one hand, it is definitely true that narrative forms of communication are very powerful. Chip and Dan Heath’s bestselling book, Made to Stick: Why Some Ideas Survive and Others Die, makes a convincing argument that good stories embody all of the elements that make information memorable and hence impactful. Good stories are simple in message, concrete in details, often unexpected and emotional and delivered by a credible speaker.
On the other hand, past work by Ubel, Jepson and Baron as well as others has shown that patient stories have the potential to bias decisions by changing how people perceive risk. Specifically, individual narratives have the potential to make rare outcomes appear equally likely as common ones. If there is one story that turns out well and another that turns out poorly, people tend to see those outcomes as equally likely even when numerical risk information is provided.
A review by Winterbottom and colleagues of the use of patient narratives in decision aids drew similarly mixed conclusions, with narratives altering health decisions in some contexts but not in others. To cite the paper:
Narrative information influenced decision making more than the provision of no additional information and/or statistically based information in approximately a third of the studies (5/17); studies employing first person narratives were twice as likely to find an effect.
More recent work (e.g., here and here) has demonstrated that narratives can alter people’s preferences for end-of-life care and increase risk perception for colorectal cancer and interest in screening.
So are patient narratives too dangerous to use in health education and risk communication contexts?
Not necessarily.
You see, all of this prior work has treated all patient narratives as if they were identical. Which, of course, is completely untrue.
A story of how one patient went about looking for information about her breast cancer treatment decision is hardly the same as a story about another patient’s experience with chemotherapy-induced fatigue.
A heartfelt account from a prostate cancer patient of how difficult it is to live with treatment induced impotence is never going to be equivalent to another man’s (or perhaps even the same man’s) upbeat description of the fact that he remains cancer-free 3 years after having radical surgery.
In order to advance the science of if, when, and how to incorporate patient narratives into health communications, we need to accept that narratives are highly heterogenous and to develop common classifications, definitions, and terms to use when developing narratives for use and when reporting them in scientific publications.
In the January 2013 issue of Medical Decision Making, Victoria Shaffer and I have published what we describe as “a purpose-, content-, and valence-based taxonomy of patient narratives in decision aids.”
We argue that all patient stories can be classified on at least three distinct dimensions:
- Purpose: Stories can have one or more of the following goals:
- To provide information
- To make materials more engaging
- To model targeted behaviors
- To persuade people to undertake healthy behaviors
- To provide comfort
- Content: Stories can include information about decision making process (e.g., what to consider, where to look for information, what values might be important), the physical or emotional experience of different conditions, the psychological or physical outcomes of a decision, or any combination of the above.
- Evaluative Valence: Stories can have a positive emotional tone, a negative tone, or be be mixed.
Our taxonomy is derived from the research literature, but it is not yet empirically validated. We expect that it will evolve over time, as we and others conduct experimental studies, identify categories or dimensions we omitted, and generally build the evidence base surrounding the use of patient narratives. In fact, we expect that some of our hypotheses may prove to be incorrect. So be it.
But, our main message is simple: Patient narratives are NOT one size fits all.
Consider, for example, the impact of our content types on risk communications. If you go back and look at the Ubel, Jepson, and Baron paper, they tested testimonials that a particular procedure went well vs. poorly. In other words, outcome narratives. We agree that outcome testimonials are likely to bias risk perceptions.
Yet, what about our other content types? Experience narratives that describe what it feels like to, say, have severe shortness of breath might improve risk communications by providing rich detail about the potential negative outcome in question. Process narratives could also be helpful by reminding people to pay attention to certain types of risks that they might otherwise forget about.
In other words, “stories” can be both helpful OR harmful, depending on type.
We wouldn’t dream of giving a patient a drug without knowing whether it was an antibiotic or an anti-inflammatory agent. (But they’re both drugs!) We would never have someone start a physical therapy exercise plan without determining which muscle groups and joints will be strengthened or strained by each exercise. (But they’re all exercises!)
By the same logic, we should strive never to use patient narratives in our communications without systematically identifying what concepts they provide, what purposes they serve, and what emotions they evoke.
Patient narratives are a powerful tool, one that we all can and should use to accomplish a variety of health communications goals. But, the persuasiveness of narratives means that they must be used intentionally and carefully.
Do you know what messages your patient narratives really sending?
Brian J. Zikmund-Fisher is an Assistant Professor of Health Behavior & Health Education at the University of Michigan School of Public Health and a member of the University of Michigan Risk Science Center and the Center for Bioethics and Social Sciences in Medicine. He specializes in risk communication to inform health and medical decision making.
New concept for reintegrating technology innovation and social needs
by Ishani Hewage on May 21, 2013
The first annual conference on Governance of Emerging Technologies: Law, Policy and Ethics has just wrapped up in Arizona, Phoenix. In his keynote speech, Technology Innovation and the New Social Responsibility, Andrew Maynard, Director of the University of Michigan Risk Science Center called for a re-think of the relationship between technology innovation and societal needs.
A new concept – Technology Innovation as Societal Insurance
“We are living in an highly interconnected world that is rapidly changing – increasing population, growing technological complexities and greater demands on harder-to-get resources,” said Andrew.
“In order to tackle evolving social challenges that range from chronic diseases to access to clean water and nutritious food, we need to find new ways of supporting technological innovations that are socially, environmentally and economically viable. We have iPads, but we live in a world where people are still dying of malaria.”
Andrew noted that, in the distant past, technology innovation was largely driven by needs of the society.
“There was no systematic methodology behind innovation – people came up with ideas, and if they helped solve a problem, they stuck and were considered successful.”
Since the industrial revolution and more recently the Second World War, economic growth has become the main driver of innovation, resulting in a disassociation between societal needs and technological innovation.
“With innovation occurring at a rate faster than which we can appropriately regulate, we run the risk of not being able to manage the adverse consequences that inevitably arise. But a lack of responsive oversight also threatens to undermine consumer and commercial buy-in to socially and environmentally important technological innovations,”
So, where to from here? How do we get back on track?
In his keynote, Andrew suggested a new approach to reintegrate technology innovation with social needs which was developed in collaboration with Chief Scientist of Environmental Disease Fund, Steve Hamburg – a concept he refers to as Technological Innovation as Societal Insurance.
“Social responsibility is key to achieving corporate success in today’s world and with this in mind, this new concept calls for strategic up-front investment in innovation that will reduce future social, environmental and fiscal liabilities – and will re-couple innovation to societal drivers.”
In order for this concept to be effective, Andrew argues that there are four key components that need to be considered.
“Firstly, to develop sustainable innovations that are economically and socially relevant, there needs to be innovative private public collaborations. This is a powerful approach, which has already been successfully demonstrated by the Gates Foundation and their continued support for eradicating malaria. The foundation has committed over $2 billion for research and innovation for effective malaria control.”
The next component, Andrew suggests, is connecting social entrepreneurs who seek to find innovative solutions to social challenges, and technology innovators who are at the cutting edge of translating research and development into new products.
“There is a growing global community of social entrepreneurs and technological pioneers. Bringing these two communities together has the potential to lead to interactions that result in a new wave of technology solutions that are both socially responsive and economically sustainable.”
Citizen engagement is also vital component of this new concept.
“The public needs to be partners in the technology innovation process. Unless the scientific and technology community and the public engage in frequent, timely and transparent dialog on innovations, the social partnerships that are essential for success will not be fostered. Such a lack of engagement and partnership stifled the development of socially responsive genetic modification technologies for many years, and continues to limit progress in the field of genetically modified organisms.”
The final component of this concept highlighted by Andrew requires new approaches to the way in which intellectual property is used and protected within society.
“We need to explore mutually beneficial approaches to balancing the IP protections and at the same time using these new technology innovations for social benefits.”
As part of a larger exploration of responsible innovation, the concept of Technology Innovation as Societal Insurance suggests a way forward to reintegrate innovation and societal needs in order to meet future challenges in a sustainable manner.
The slides from Andrew’s keynote can be viewed here.
{ 0 comments }